Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. Journey Medical Corp is focused on identifying, acquiring, developing and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.
SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling...
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a...
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.31 | -5.3726169844 | 5.77 | 6.2 | 5.32 | 57891 | 5.78504959 | CS |
4 | 0.1 | 1.86567164179 | 5.36 | 6.2 | 4.84 | 71220 | 5.38118748 | CS |
12 | 1.97 | 56.446991404 | 3.49 | 6.2 | 3.2001 | 84935 | 4.67995818 | CS |
26 | 0.46 | 9.2 | 5 | 6.2 | 2.85 | 131730 | 4.27176033 | CS |
52 | 3.6599 | 203.316482418 | 1.8001 | 8.11 | 1.6 | 158877 | 4.63199621 | CS |
156 | -3.24 | -37.2413793103 | 8.7 | 10.2 | 1.02 | 96980 | 4.35618684 | CS |
260 | -2.93 | -34.9225268176 | 8.39 | 25.99 | 1.02 | 359654 | 11.34602109 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.